Search Within

Simone Susanne Krebs

Formats
  1. Journal Article (25)
  2. Meeting Abstract (20)
  3. Review (5)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Book Section (1)
Groups
  1. Molecular Imaging and Therapy Service (55)
  2. Radiology, Department of (55)
  3. Sloan Kettering Institute Postdocs (36)
  4. Medical Physics (31)
  5. Department of Medicine (23)
  6. GSK Faculty (23)

More Groups

People
  1. Heiko Schoder (21)
  2. Lukas Carter (13)
  3. Steven Larson (13)
  4. Lisa Bodei (10)
  5. Darren Veach (9)
  6. Wolfgang Weber (9)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (6)
  6. 2020 (5)

More Years

Publications
  1. Journal of Nuclear Medicine (15)
  2. European Journal of Nuclear Medicine and Molecular Imaging (12)
  3. Clinical Nuclear Medicine (4)
  4. EJNMMI Physics (2)
  5. Frontiers in Oncology (2)
  6. Journal of Neuro-Oncology (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (15)
  2. Springer (14)
  3. Lippincott Williams & Wilkins (6)
  4. Elsevier Inc. (3)
  5. Biomed Central Ltd (2)
  6. Elsevier Science Inc. (2)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of [(18)F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
    Journal Article

    Krebs, S.; Mauguen, A.; Yildirim, O.; Hatzoglou, V.; Francis, J. H.; Schaff, L. R.; Mellinghoff, I. K.; Schöder, H.; Grommes, C.
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Engineered cells as a test platform for radiohaptens in pretargeted imaging and radioimmunotherapy applications
    Journal Article

    Dacek, M. M.; Veach, D. R.; Cheal, S. M.; Carter, L. M.; McDevitt, M. R.; Punzalan, B.; Burnes Vargas, D.; Kubik, T. Z.; Monette, S.; Santich, B. H.; more...
    Bioconjugate Chemistry (2021)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Journal Article

    Krebs, S.; O'Donoghue, J. A.; Biegel, E.; Beattie, B. J.; Reidy, D.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • First-in-humans trial of dasatinib-derivative tracer for tumor kinase-targeted PET
    Journal Article

    Krebs, S.; Veach, D. R.; Carter, L. M.; Grkovski, M.; Fornier, M.; Mauro, M. J.; Voss, M. H.; Danila, D. C.; Burnazi, E.; Null, M.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • CAR chase: Where do engineered cells go in humans?
    Editorial

    Krebs, S.; Dacek, M. M.; Carter, L. M.; Scheinberg, D. A.; Larson, S. M.
    Frontiers in Oncology (2020)

    Fulltext@MSK | Save
  • Laboratory-proven asymptomatic SARS-CoV-2 (COVID-19) infection on (18)F-FDG PET/CT
    Miscellaneous

    Krebs, S.; Petkovska, I.; Ho, A. L.; Ulaner, G. A.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pharmacokinetic assessment of (18)F-(2S,4R)-4-fluoroglutamine in patients with cancer
    Journal Article

    Grkovski, M.; Goel, R.; Krebs, S.; Staton, K. D.; Harding, J. J.; Mellinghoff, I. K.; Humm, J. L.; Dunphy, M. P. S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Prognostic value of [(18)F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab
    Meeting Abstract

    Graham, M.; Krebs, S.; Bale, T.; Domfe, K.; Lobaugh, S.; Zhang, Z.; Dunphy, M.; Kaley, T.; Young, R.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan
    Journal Article

    Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies
    Meeting Abstract

    Krebs, S.; Wolfe, J.; Mellinghoff, I.; Grommes, C.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save